Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Coronary artery occlusion
ADR ID BADD_A01099
ADR Hierarchy
12      Injury, poisoning and procedural complications
12.02      Procedural related injuries and complications NEC
12.02.01      Cardiac and vascular procedural complications
12.02.01.036      Coronary artery occlusion
02      Cardiac disorders
02.02      Coronary artery disorders
02.02.01      Coronary artery disorders NEC
02.02.01.006      Coronary artery occlusion
24      Vascular disorders
24.04      Arteriosclerosis, stenosis, vascular insufficiency and necrosis
24.04.04      Coronary necrosis and vascular insufficiency
24.04.04.013      Coronary artery occlusion
Description Complete blockage of blood flow through one of the CORONARY ARTERIES, usually from CORONARY ATHEROSCLEROSIS. [MeSH]
MedDRA Code 10011086
MeSH ID D054059
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Coronary artery occlusion | Coronary occlusion | Coronary occlusion without myocardial infarction | Occlusion coronary | Occlusion coronary artery | Left anterior descending coronary artery occlusion | Left main coronary artery occlusion | Coronary Occlusion | Coronary Occlusions | Occlusion, Coronary | Occlusions, Coronary
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D00014Abiraterone0.000501%
BADD_D00121Amlodipine0.000006%
BADD_D00158Aprotinin (bovine)--
BADD_D00161Argatroban--
BADD_D00285Bosentan0.000542%
BADD_D00349Capecitabine0.000112%
BADD_D00364Carboplatin0.000112%
BADD_D00410Celecoxib0.000050%
BADD_D00417Cetirizine0.000029%
BADD_D00504Clopidogrel0.000107%
BADD_D00560Cytarabine0.000112%
BADD_D00563Dabigatran0.001835%
BADD_D00574Dalfampridine0.000538%
BADD_D00621Desvenlafaxine--
BADD_D00622Desvenlafaxine succinate--
BADD_D00623Dexamethasone0.000145%
BADD_D00732Droxidopa0.000127%
BADD_D00734Duloxetine0.000027%
BADD_D00792Eptifibatide--
BADD_D00931Fluorouracil0.000184%
BADD_D01020Glatiramer--
BADD_D01021Glatiramer acetate--
BADD_D01119Ibrutinib0.000224%
BADD_D01136Imatinib0.000168%
BADD_D01260Leuprolide acetate0.003585%
BADD_D01285Levothyroxine0.000005%
BADD_D01311Lomitapide0.000021%
BADD_D01336Macitentan0.000181%
BADD_D01352Maraviroc--
BADD_D01418Methotrexate--
The 1th Page    1 2 3    Next   Last    Total 3 Pages